In a filing with the New Jersey Department of Labor & Workforce Development, Merck said it expects to cut 204 positions at its headquarters in Rahway between February and May 2026. This marks the ...

Bristol Myers Squibb is securing an opportunity to compete in the next generation of cell therapies through the $1.5 billion acquisition of Orbital Therapeutics, a startup with a lead program nearing ...

On the heels of the launch of an online direct-to-patient (DTP) program offering discounted Eliquis to certain U.S. patients, Bristol Myers Squibb is putting Sotyku at the center of its next DTP ...

#OctopusEffects, #Blender tutorial to model a cute puppy with Modifier in Blender 3.3 Timestamp 00:00 Introduction 00:10 Body 00:46 Nose 02:09 Tongue 03:36 Ears 05:32 Cheeks 06:13 Eyes 07:01 Setup ...

#OctopusEffects, #Blender Modeling a female robot using basic commands in Blender 3.3 Subscribe! subscribe Hegseth orders rare, urgent meeting of hundreds of generals, admirals Biden’s Final Pardons ...

Both BMS and Novo Nordisk have, in recent months, announced steep layoffs as they strive to cut back on costs. The New Jersey biotech sector suffered a major blow on Wednesday with both Novo Nordisk ...

Kendall Jenner is all about the simple life. The supermodel, 29, has revealed plans to quit her high-powered modeling career and step out of the spotlight for good, instead shifting her focus to her ...

Bristol Myers Squibb has raided AstraZeneca to find its next chief medical officer, persuading Cristian Massacesi, M.D., to leave the Anglo-Swedish drugmaker and take responsibility of all its product ...

Forbes contributors publish independent expert analyses and insights. I write about the economics of AI. The AI boom has been defined by unprecedented innovation across nearly every sector. From ...

Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...